Transitioning to Life With COVID-19: A New Normal

Rhea-AI Impact
Rhea-AI Sentiment

NORTHAMPTON, MA / ACCESSWIRE / February 8, 2023 / As COVID-19 transitions from pandemic to endemic, we're learning to live a "new normal." Reported levels of COVID-19 vary by region, with most states adjusting masking requirements in public areas. Employees are returning to on-site work, and children are back to in-school learning.

Quest proactively established our "Back to Life" effort including multiple partnerships and initiatives to help communities safely return to on-site work, school, and recreational activities.

In the coming pages, we'll discuss many of our successful endeavors and how they're helping so many to return to all aspects of life.

  • Back to working on-site: Many Quest employees are successfully transitioning from working remotely to returning safely to working on-site (p. 19).
  • Back to school: Read about how Quest helped children across the country return to in-school learning (p. 20).
  • Back to recreation: Quest's innovative new programs and collaborations are getting people back to recreation, including travel, sporting events, and more (p. 21).

Read More

Quest Diagnostics , Wednesday, February 8, 2023, Press release picture

View additional multimedia and more ESG storytelling from Quest Diagnostics on

Contact Info:
Spokesperson: Quest Diagnostics

SOURCE: Quest Diagnostics

View source version on

Quest Diagnostics Incorporated


DGX Rankings

DGX Latest News

DGX Stock Data

Medical Laboratories
Health Care and Social Assistance
United States of America

About DGX

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator